STOCK TITAN

Phathom Pharmaceuticals to Host Virtual Investor Day

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Phathom Pharmaceuticals (Nasdaq: PHAT) will host a virtual Investor Day on December 14, 2020, from 1 PM to 3:30 PM ET. The event will feature members of Phathom's management team and gastroenterology experts discussing the company's pipeline and commercial strategy. Interested participants can pre-register for the event. A replay and presentation slides will be available post-event on Phathom's website.

Positive
  • None.
Negative
  • None.
  • Event to be webcast on Monday, December 14, 2020 at 1:00 PM (ET)

FLORHAM PARK, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today confirmed it will host a virtual Investor Day on December 14, 2020 from 1 pm to 3:30 pm Eastern Time. Members of Phathom’s management team and gastroenterology key opinion leaders will provide updates on the company’s pipeline and commercial strategy.

Those interested in participating are invited to pre-register at http://bit.ly/PHAT-investor-day-2020. A replay of the webcast and the slide presentation will be available after the meeting on the News & Events section of the Phathom website at https://investors.phathompharma.com/.  

About Phathom
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders. For more information about Phathom, visit the Company’s website at www.phathompharma.com or follow the Company on LinkedIn at www.linkedin.com/company/phathompharma.

CONTACTS

Media Contact:
Nick Benedetto
1-877-742-8466
media@phathompharma.com

Investor Contact:
Todd Branning
1-877-742-8466
ir@phathompharma.com


FAQ

When is the Phathom Pharmaceuticals Investor Day event?

Phathom Pharmaceuticals will host its Investor Day on December 14, 2020, from 1 PM to 3:30 PM ET.

How can I register for the Phathom Investor Day?

Interested participants can pre-register for the Phathom Investor Day at https://www.globenewswire.com/Tracker?data=OOhXNn415q90wtQpo0H23tILyxNFaKEhGyiY-UV_2z-XN7jrfIrWSDUariRHWP_1_oneJoVCDafkKkqqVladX3gySZkl7cJuNnZxmoKjdiMs7Lc5nfe_QOKsy6hqIIkd.

Will the Phathom Pharmaceuticals Investor Day be available for replay?

Yes, a replay of the Phathom Pharmaceuticals Investor Day and the presentation slides will be available after the event on their website.

What topics will be covered in the Phathom Pharmaceuticals Investor Day?

The event will include updates on Phathom Pharmaceuticals' pipeline and commercial strategy presented by management and gastroenterology experts.

What is the stock symbol for Phathom Pharmaceuticals?

Phathom Pharmaceuticals is listed under the stock symbol PHAT.

Phathom Pharmaceuticals, Inc.

NASDAQ:PHAT

PHAT Rankings

PHAT Latest News

PHAT Stock Data

555.22M
51.10M
7.73%
109.32%
20.55%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
FLORHAM PARK